A New Dawn For The Healthcare Industry
Market Expertz | February 21, 2019
We cannot deny the importance of healthcare and its ubiquitous requirements. With new forms of diseases and viruses being discovered, the field observes technological advancements continually. Besides that, scientists are always exploring therapeutic options in hopes to achieve a cure for existent diseases. The internet has handed people a prevalent database to aid them in self-medication, and this calls for the need to ‘healthify’ the daily consumer goods. The technological advancements have opened up immense possibilities for the intersection of the healthcare industry with others. The consumer healthcare industry has observed a few notable mergers and acquisitions recently. The Indian pharma giant Zydus Cadila bought Heinz India, parented by US-based Kraft Heinz, that owns popular brands like Complan and Glucon D. Hindustan Unilever, the Indian subsidiary of the British-Dutch Unilever, has acquired the GlaxoSmithKline’s Horlicks, Boost and Maltova. Rising awareness among consumers regarding healthy food and its positive influence on their lifestyles is prominently increasing the demand for the market.
Along with its penetration into daily nutritional goods, the healthcare industry has also made remarkable progress on the medical front. The World Health Organization recently released a report on the pricing of cancer drugs that has sparked the age-old debate of the economics of cancer medicines. The cancer drug industry has new hope as two Israeli neuroscientists Dr. Efrat Shavit-Stein and Professor Yoav Chapman have introduced the drug called “SIXAC” that can potentially cure an aggressive form of brain cancer, Glioblastoma (GBM). The Swiss healthcare company Roche hopes to gain FDA approval for two cancer drugs “Entrectinib” that has anti-tumor properties and “Polatuzumab Vedotin” which is used in the treatment of Follicular Lymphoma, by the end of 2019. Novartis has received approval from health authorities in the UK for the use of its Kymriah cell therapy, which was originally used for relapses, to be used in treatment for adult lymphoma patients. A new drug called “Tisotumab Vedotin” claims to cure six types of cancer.
The field of robotics has found its way into the surgical realm and is successfully performing complicated procedures. In the first-of-its-kind operation in Asia, a two-day-old new born with oesophageal atresia, i.e. the absence of a food pipe was treated successfully by robotic surgery. These instances exhibit the inevitable growth of the healthcare market. The technological advancements in pharmaceutical and consumer goods promises a positive future for the healthcare market.
Read more at: https://www.marketexpertz.com/report/category/pharma-and-healthcare